|
Total Topoisomerase I assay
|
BAO_0010276 |
|
|
MET immunoassay
|
BAO_0010271 |
|
|
thermal degradation product
|
CHEBI_77521 |
|
|
γH2AX, pNBS1, and β-catenin Multiplex Immunofluorescence Assay
|
BAO_0010273 |
|
|
PAR Immunoassay
|
BAO_0010272 |
|
|
Maillard reaction product
|
CHEBI_77523 |
|
|
alkylating agent
|
CHEBI_22333 |
|
|
delta-opioid agent
|
CHEBI_60601 |
|
|
preclinical study
|
BAO_0010278 |
|
|
Ehrlich tumor carcinoma
|
DOID_5050 |
|
|
kappa-opioid agent
|
CHEBI_60603 |
|
|
dacryoadenitis
|
DOID_950 |
|
|
malignant granular cell myoblastoma
|
DOID_5042 |
|
|
hypersplenism
|
DOID_6376 |
|
|
adrenergic uptake inhibitor
|
CHEBI_35640 |
|
|
biosensor method
|
BAO_0010264 |
|
|
pycnodysostosis
|
DOID_0080038 |
|
|
CEREP assay
|
BAO_0010263 |
|
|
Epitope Mapping
|
BAO_0010266 |
|
|
Annexin V apoptosis assay
|
BAO_0010265 |
|
